Andrew+
Andrew+ is based upon 6 years of market feedback, and builds on the success of the Andrew Pipetting Robot. It now enables both fully automated pipetting, as well as the more complex manipulation and grabbing of microplates, tubes and columns, through an expanding range of Andrew+ Accessories. It can also execute protocols designed in OneLab, enabling you to quickly transition from laborious manual procedures to error-free,…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Andrew+ is based upon 6 years of market feedback, and builds on the success of the Andrew Pipetting Robot. It now enables both fully automated pipetting, as well as the more complex manipulation and grabbing of microplates, tubes and columns, through an expanding range of Andrew+ Accessories.
It can also execute protocols designed in OneLab, enabling you to quickly transition from laborious manual procedures to error-free, easily programmable fully-robot workflows.
Exploring PROTACs in drug discovery and development
Proteolysis targeting chimeras (PROTACs) are able to degrade disease-causing proteins by hijacking the cells own degradation pathway. These molecules are therefore changing the drug discovery landscape by enabling targeting for previously 'undruggable' proteins.
Explore advanced LC-MS bioanalytical solutions that can support your PROTAC workflow to confidently quantify and accelerate development with sensitivity, selectivity and reproducibility.
